Novartis: Scaling Breakthroughs to Reach Patients Worldwide

Swiss innovative medicines company Novartis is turning its operations network into a strategic engine for patient access, using automation, digital tools and AI to deliver increasingly complex therapies at global scale. At the centre of that effort is Steffen Lang, the company’s President, Operations, who has been with Novartis for over 30 years helping to shape how it manufactures and supplies medicines around the world.

At its core, this story reflects on how a pharmaceutical company developing cutting-edge and life-saving medicines has had to rethink how it plans, produces and delivers treatments at global scale. For Novartis, this has consisted of building reliable supply for therapies that are often complex, personalised and time-sensitive. To enable this, it has developed and deployed digital tools, automation and AI to make supply chains faster, more visible and resilient.

As a leading healthcare company focused on innovative medicines, Novartis operates around its mission to improve and extend lives.